A new injectable weight loss treatment from the maker of Ozempic and Wegovy delivered 23% weight loss in trials, according to ...

Novo Nordisk said Hims & Hers has “failed to adhere to the law which prohibits mass sales of compounded drugs” under the ...

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...

NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.

Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs. The ...

A BBC News presenter has gone viral after replacing the term “pregnant people” to “women” while reading the autocue during a ...

Eisai Limited, a leading research and development-based pharmaceutical company specializing in neurology and oncology, has ...